Altman Z-Score:
11.78-0.33(-2.73%)Summary
- As of today, CRSP Altman Z-Score is 11.78, with the most recent change of -0.33 (-2.73%) on October 16, 2025.
- CRSP current Altman Z-Score indicates the stock has a low bankruptcy risk.
Performance
CRSP Altman Z-Score Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Altman Z-Score Formula
Z-Score = 1.2*A + 1.4*B + 3.3*C + 0.6*D + 1.0*E- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
CRSP Altman Z-Score Trends
| PeriodPeriod | Altman Z-ScoreAltman Z-Score | PricePrice | Market CapMarket Cap |
|---|---|---|---|
| 1D1 Day | -2.7% | -2.6% | -2.6% |
| 1M1 Month | +15.0% | +14.3% | +14.3% |
| 3M3 Months | +32.4% | +26.9% | +30.6% |
| 6M6 Months | +103.8% | +85.2% | +95.0% |
| YTDYTD | +96.3% | +77.7% | +88.5% |
| 1Y1 Year | +59.0% | +42.8% | +52.2% |
| 5Y5 Years | -68.7% | -36.3% | -17.9% |
CRSP Altman Z-Score History
| Date | Value |
|---|---|
| 2025 | 11.78(+96.3%) |
| 2024 | 6.00(-32.2%) |
| 2023 | 8.85(+91.6%) |
| 2022 | 4.62(-60.2%) |
| 2021 | 11.62(-72.0%) |
| Date | Value |
|---|---|
| 2020 | 41.46(+123.1%) |
| 2019 | 18.58(+122.2%) |
| 2018 | 8.36(+26.7%) |
| 2017 | 6.60(+32.3%) |
| 2016 | 4.99 |
FAQ
- What is CRISPR Therapeutics AG altman z-score?
- What is CRSP altman z-score year-to-date change?
- What is CRISPR Therapeutics AG altman z-score year-on-year change?
What is CRISPR Therapeutics AG altman z-score?
The current altman z-score of CRSP is 11.78
What is CRSP altman z-score year-to-date change?
CRISPR Therapeutics AG altman z-score has changed by +5.78 (+96.33%) since the beginning of the year
What is CRISPR Therapeutics AG altman z-score year-on-year change?
Over the past year, CRSP altman z-score has changed by +4.37 (+58.97%)